Lymphoma Drug Undergoing Trial Makes MS Relapses 5 Times Less Likely
A lymphoma drug undergoing a phase 3 clinical trial hopes to make multiple sclerosis relapses five times less likely.
from Medical Daily https://www.medicaldaily.com/lymphoma-drug-undergoing-trial-makes-ms-relapses-5-times-less-likely-466215?utm_source=Public&utm_medium=Feed&utm_campaign=Distribution
from Medical Daily https://www.medicaldaily.com/lymphoma-drug-undergoing-trial-makes-ms-relapses-5-times-less-likely-466215?utm_source=Public&utm_medium=Feed&utm_campaign=Distribution
Comments
Post a Comment